Man Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Sell |
34,013
-94,593
| -74% | -$5.23M | ﹤0.01% | 1240 |
|
|
2025
Q1 | $6.22M | Sell |
128,606
-29,357
| -19% | -$1.42M | 0.02% | 787 |
|
|
2024
Q4 | $6.1M | Buy |
157,963
+102,132
| +183% | +$3.94M | 0.02% | 824 |
|
|
2024
Q3 | $2.51M | Buy |
55,831
+48,176
| +629% | +$2.17M | 0.01% | 1120 |
|
|
2024
Q2 | $265K | Buy |
+7,655
| New | +$265K | ﹤0.01% | 1678 |
|
|
2023
Q1 | – | Sell |
-94,070
| Closed | -$1.03M | – | 2160 |
|
|
2022
Q4 | $1.03M | Buy |
94,070
+14,135
| +18% | +$154K | ﹤0.01% | 1313 |
|
|
2022
Q3 | $674K | Buy |
+79,935
| New | +$674K | ﹤0.01% | 1388 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1847 |
|
|
2018
Q3 | – | Sell |
-86,126
| Closed | -$579K | – | 2178 |
|
|
2018
Q2 | $579K | Buy |
+86,126
| New | +$579K | ﹤0.01% | 1756 |
|